Insider buying last 90 days
No open-market insider purchases were filed for ABEV in the last 90 days.
From Form 4 filings, dated to when each was filed.
Close on Sep 18, 2026. Page updated Sep 19, 9:15 pm ET.
Ambev trades at $2.94, down 1.3% on the day, sitting between its 50-day average of $2.98 and 200-day average of $2.94. The GekkoIndex reads 62.3, placing the stock in the Accumulation zone. Against Gekko Fair Value of $4.13, price stands 28.8% below that mark. Over the past year the stock has returned 24.6%, though the three-month return is -5.8% and the six-month return is 5%.
Recent filings show two institutional moves in opposite directions. Tidal Investments LLC cut its stake by 15.9% in the second quarter, selling 488,057 shares while retaining 2.58 million shares valued at $8.09 million. Engineers Gate Manager LP increased its position by 712.8% in the same quarter, bringing its holding to $5.77 million, even as analyst sentiment is described as cautious with an average "Reduce" rating and a target near the current price.
Ambev's next earnings date falls on 29 October 2026, 39 days out and beyond a typical 20-trading-day holding window. At the last report, EPS of $0.28 beat the $0.05 estimate, part of a streak of 5 beats in 8 quarters, with an average absolute reaction of 4.6% historically. Analyst coverage from 3 firms shows 0 buy, 2 hold, and 1 sell, with a consensus target of $3.34. Seasonality over the next 20 trading days has averaged -4.6% across 5 years, with 0 of those years positive, a pattern worth noting alongside the current gap to fair value.
Written by AI and checked automatically against the figures on this page. Generated Sep 20, 2026 from the data above.
Ambev scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed1 headwind
Averages disagree
Close $2.94 sits between the 50-day ($2.98) and 200-day ($2.94) averages, or the averages disagree.
See the chart62.3, Accumulation
Reading 62.3 is in the Accumulation zone.
See the GekkoIndex28.8% below
Price is 28.8% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 39 days
Next report Oct 29, 2026, 39 days away — outside a typical 20-trading-day hold.
See earnings−4.6% on average
From this point in the calendar, the next 20 trading days averaged −4.6% over 5 years, rising in 0 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Ambev closed at $2.94 on Sep 18, 2026, +24.6% over the past year, inside a 52-week range of $2.10 to $3.45.
Use the left and right arrow keys to read daily values.
Put ABEV on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Ambev produces and sells a broad line of drinks, along with some food items, throughout the Americas. Beer forms a large part of its business, with labels ranging from Skol, Brahma and Antarctica to global names such as Corona, Stella Artois, Budweiser and Michelob Ultra. Alongside beer, it offers non-alcoholic choices like bottled water, juices, iced tea, energy drinks and sodas under brands including Guaraná Antarctica, Gatorade, Pepsi and Lipton Iced Tea.
Its business is split into four regional units covering Brazil, Central America together with the Caribbean, the rest of South America, and Canada. Getting goods to market relies on a combination of Ambev's own delivery operations and outside distribution partners. Interbrew International B.V. holds a controlling interest in the company, making Ambev part of that larger corporate structure.
Ambev's origins go back to 1885, and its main offices sit in São Paulo, Brazil. Its stock trades under the ticker ABEV.
Ambev’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 62.3, in the Accumulation zone, up 5.8 points over five sessions.
Up 5.8 points over five sessions, from the Neutral zone.
Reading for Sep 18, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 25 | +1.2% | +2.3% | ||
| Accumulation (current zone) | 236 | +0.4% | +0.2% | ||
| Neutral | 298 | −0.1% | +1.6% | ||
| Distribution | 56 | +1.0% | +0.5% | ||
| Selling | 0 | Not available | |||
Average ABEV share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Ambev trades 28.8% below Gekko Fair Value of $4.13, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Ambev shares are worth, recalculated every trading day.
$4.13
Gekko Fair Value, Sep 19, 2026
28.8% Undervalued
No open-market insider purchases were filed for Ambev, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for ABEV in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in ABEV were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Ambev reports on Oct 29, 2026 (39 days away), and beat the EPS estimate in 5 of its last 8 reports.
Oct 29, 2026
39 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Feb 12, 2026 | $0.28 est $0.05 | $5.23B est $4.62B | +2.0% |
| Oct 30, 2025 | $0.04 est $0.04 | $3.91B est $4.77B | +6.0% |
| Jul 31, 2025 | $0.18 est $0.03 | $3.70B est $4.16B | −5.2% |
| May 6, 2025 | $0.04 est $0.04 | $3.85B est $3.81B | +1.6% |
| Feb 26, 2025 | $0.05 est $0.05 | $4.36B est $3.82B | +11.6% |
| Oct 31, 2024 | $0.04 est $0.04 | $3.82B est $3.96B | −5.3% |
| Aug 1, 2024 | $0.03 est $0.03 | — | +0.5% |
| May 8, 2024 | $0.05 est $0.04 | — | −4.9% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Ambev is $3.34, +13.6% from the last close, from 3 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 3 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Aug 11 | UBS | $2.85 | −3.1% |
| Aug 3 | Bernstein | — | — |
| Jul 30 | Barclays | $3.50 | +19.0% |
| Jul 28 | Barclays | $3.50 | +19.0% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Sep 19, Ambev averaged −4.6% across the last 5 years, rising in 0 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −2.9% | 0 of 5 |
| Next 10 trading days | −1.5% | 2 of 5 |
| Next 15 trading days | −4.7% | 0 of 5 |
| Next 20 trading days | −4.6% | 0 of 5 |
| Next 30 trading days | −0.8% | 3 of 5 |
For scale, ABEV’s typical 20-trading-day move in either direction is about 5.5%.
Ambev’s market cap is $45.43B, with a P/E ratio of 14.9 and revenue of $88.27B over the last twelve months.
2 headlines about Ambev from the past week, newest first, each linking to the publisher.
Ambev’s market cap is $45.43B at the Sep 18, 2026 close of $2.94, with 15.42B shares outstanding. The shares trade on a P/E ratio of 14.9.
The consensus analyst 12-month price target for Ambev is $3.34, +13.6% from the last close. Of the 3 firms that rated the stock in the last 90 days, 0 rate it a buy, 2 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Ambev is undervalued: the Sep 18, 2026 close of $2.94 is 28.8% below Gekko Fair Value of $4.13. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Ambev is expected to report on Oct 29, 2026 (39 days away). Analysts expect earnings of $0.05 per share on revenue of $4.25B. Ambev beat the earnings estimate in 5 of its last 8 reports, moving 4.6% on average across the report.
Ambev’s 52-week high is $3.45 and its 52-week low is $2.10; it closed at $2.94 on Sep 18, 2026, +24.6% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and earnings risk), 1 as mixed (trend) and 1 as a headwind (seasonality). The checklist is a description of current data, not a recommendation.
Prices and signals update after every US market close; the GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,349 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.